Everolimus associated interstitial pneumonitis in a liver transplant patient

Atif S. Siddiqui, Janice L. Zimmerman

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Abstract

Drug-induced interstitial lung disease is associated with significant morbidity and mortality. Everolimus is an inhibitor of mTOR, a mammalian target of rapamycin, used as an immunosuppressant agent in solid organ transplant. Everolimus has been associated with interstitial lung disease in solid organ transplant patients but has been rarely reported in the liver transplant patient population. We report a case of interstitial pneumonitis in a liver transplant patient associated with everolimus which completely resolved after discontinuation of the medication.

Original languageEnglish (US)
Pages (from-to)15-17
Number of pages3
JournalRespiratory Medicine Case Reports
Volume19
DOIs
StatePublished - 2016

Keywords

  • Everolimus
  • Interstitial pneumonitis
  • Liver transplantation

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Fingerprint

Dive into the research topics of 'Everolimus associated interstitial pneumonitis in a liver transplant patient'. Together they form a unique fingerprint.

Cite this